Insider Transactions
Date | Filing | Filer | Title | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Apr 29, 2020 | Form 4 |
Director
Trans History: 37
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,000 | -- | 4,000 |
Apr 29, 2020 | Form 4 |
Director
Trans History: 59
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,000 | -- | 5,000 |
Apr 29, 2020 | Form 4 |
Director
Trans History: 76
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,000 | -- | 5,500 |
Apr 29, 2020 | Form 4 |
Director
Trans History: 107
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,000 | -- | 5,500 |
Apr 30, 2020 | Form 4 |
Director
Trans History: 167
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 695 | -- | 66,480 |
Apr 30, 2020 | Form 4 |
Director
Trans History: 37
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 435 | -- | 816 |
Apr 30, 2020 | Form 4 |
Director
Trans History: 59
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 435 | -- | 30,819 |
May 13, 2020 | Form 4 |
Director
Trans History: 37
|
Director | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 2,500 | -- | 12,082 |
May 13, 2020 | Form 4 |
Director
Trans History: 37
|
Director | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 130 | -- | 12,212 |
May 13, 2020 | Form 4 |
Director
Trans History: 37
|
Director | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 2,500 | -- | 2,500 |
Data provided by Kaleidoscope.
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.